Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
Macrophage production of TGF-beta and regulation by TGF-beta.
[TGF-beta family (TGF-beta, activin, BMP)].
Chemotactic response of embryonic limb bud mesenchymal cells and muscle-derived fibroblasts to transforming growth factor-beta.
TGF-beta was not chemokinetic at these levels.
TGF-beta and functional differentiation.
TGF-beta signal transduction.
TGF-beta in glomerular disease.
Regulation of differentiation by TGF-beta.
TGF-beta and calcitriol.
[Diabetic nephropathy and TGF-beta].
TGF-beta receptor signaling.
[TGF-beta: usage in nephrology].
TGF-beta mRNA expression was weak for all isoforms with TGF-beta 1 > TGF-beta 3 >> TGF-beta 2.
TGF-beta: a balancing act.
[TGF-beta and its receptors].
[TGF-beta and platelet].
TGF-beta and cancer.
TGF-beta in uveal melanoma.
Role of TGF-beta in oncogenesis.
TGF-beta and colorectal carcinogenesis.
TGF-beta was detected by immunohistochemistry.
Latent-TGF-beta: an overview.
TGF beta-related pathways.
TGF-beta signaling pathways.
This effect is potentiated by TGF-beta.
TGF-beta: problems and prospects.
TGF beta is growth inhibitory.
TGF-beta and wound healing.
Mechanisms in TGF-beta action.
The effects of TGF-beta on bone.
Introduction: what is TGF-beta?
TGF beta and HIV infection.
Receptors for the TGF-beta family.
TGF-beta receptors and actions.
TGF-beta was not mitogenic at these dosages.
Clinical potential for TGF-beta.
Immunoregulation and TGF-beta 1.
Porcine granulosa cells do not express transforming growth factor-beta 2 (TGF-beta 2) messenger ribonucleic acid: molecular basis for their inability to produce TGF-beta activity comparable to that of rat granulosa cells.
TGF-beta 2 was undetectable.
TGF-beta and fibrosis.
TGF beta inhibitors.
Controlling TGF-beta signaling.
TGF-beta signaling in chondrocytes.
TGF-beta in atherosclerosis.
[TGF-beta signaling and carcinogenesis].
TGF-beta activation by traction?
Tgf-Beta signaling in development.
Focus on TGF-beta signalling.
[The role of TGF beta].
Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
TGF-beta is a potent immunosuppressant.
TGF-beta: friend or foe? The role of TGF-beta/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy.
TGF-beta: friend or foe?
TGF-beta and hepatocellular carcinoma.
TGF-Beta to the rescue.
TGF-beta and atherosclerosis in man.
TGF-beta and cancer.
TGF-beta and osteoarthritis.
Is TGF-beta a stemness regulator?
TGF-beta signaling in fibrosis.
TGF-beta in aging and disease.
The paradoxical TGF-beta vasculopathies.
Upregulation of intervertebral disc-cell matrix synthesis by pulsed electromagnetic field is mediated by bone morphogenetic proteins.
TGF-beta was not upregulated by PEMF.
Caveolin and TGF-beta entanglements.
TGF-beta in transplantation tolerance.
TGF-beta as target in oncology.
Plasticity of TGF-beta signaling.
Role of TGF-beta in melanoma.
TGF-beta and microvessel homeostasis.
Ever developing TGF-beta.
This model suggests that the present day TGF-beta gene family consists of four members: TGF-beta 1 (= TGF-beta 4), TGF-beta 2, TGF-beta 3, and TGF-beta 5.
Tumor necrosis factor-alpha is chemokinetic for lymphokine-activated killer cells: regulation by cyclic adenosine monophosphate.
The activity of TGF-beta 1 was reversed by anti-TGF-beta 1 antibody.
The TGF-beta effect was blocked specifically by a monoclonal anti-TGF-beta antibody.
Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells.
Addition of anti-TGF-beta antagonized the effects of endogenous TGF-beta.
Secretion of transforming growth factor-beta isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation.
This active TGF beta is the major component of the TGF-beta activity in this CM.
Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
In contrast, TGF beta sRII was less effective in neutralization of TGF-beta 2.
Immunoreactive TGF beta 1 and TGF beta 2 were measured by ELISA.
Interleukin-2 suppresses activated macrophage intracellular killing activity by inducing macrophages to secrete TGF-beta.
This increase in secretion of TGF-beta was not dependent increases in TGF-beta 1 mRNA.
There was no crossreactivity between the TGF beta 1 and TGF beta 3 isoforms.
Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion.
TGF-beta is activated by dissociation of LAP from the mature TGF-beta.
Immunolocalization of transforming growth factor-beta 1 and transforming growth factor-beta 2 in the mouse ovary during gonadotrophin-induced follicular maturation.
Staining for TGF beta 1 and TGF beta 2 persists in the oocyte.
Tumor necrosis factor antibody treatment of septic baboons reduces the production of sustained T-cell suppressive factors.
Levels of active TGF-beta and the drop in latent TGF-beta were decreased.
TGF-beta is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-beta 1 and TGF-beta 3.
Differential effects of TGF-beta 1 and TGF-beta 3.
Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.
TGF-beta 1 and TGF-beta 2 are implicated in cutaneous scarring.
Effects of transforming growth factor beta on corneal epithelial and stromal cell function in a rat wound healing model after excimer laser keratectomy.
The increased stromal cells expressed TGF-beta isoforms and TGF-beta receptors.
Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
TGF-beta overexpression did not affect TGF-beta response.
Transforming growth factor beta is a growth-inhibitory cytokine of B cell lymphoma in SIV-infected macaques.
TGF-beta activity was blocked by a specific anti-TGF-beta antibody.
The progression of invasiveness regarding the role of transforming growth factor beta receptor type II in gastric cancer.
The expression of TGF beta receptors is required for the effect of TGF beta.
Expression of transforming growth factor beta(1), beta(3), and basic fibroblast growth factor in full-thickness skin wounds of equine limbs and thorax.
TGF-beta(1) and TGF-beta(3) show a reciprocal temporal regulation.
Exogenous TGF-beta rescued the TGF-beta-deprived phenotype.
Upregulation of TGF-beta RI and TGF-beta RII was also detected.
Release of biologically active TGF-beta from airway smooth muscle cells induces autocrine synthesis of collagen.
The TGF-beta associated with LTBP-1 localizes TGF-beta extracellularly.
Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases.
FLP activity is not modulated by exogenous TGF-beta or neutralizing TGF-beta Abs.
Smad3 mediates the TGF-beta-induced contraction of type I collagen gels by mouse embryo fibroblasts.
TGF-beta signals through TGF-beta receptors and Smad proteins.
TGF-beta 2 has similar effects to TGF-beta 1.
Characterization of polyclonal anti-peptide antibodies specific for transforming growth factor beta 2.
TGF beta 1 was not recognized by the anti-TGF beta 2 peptide antiserum.
The effect of TGF-beta was reversed by subculturing the treated cells without TGF-beta.